Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHuppert, Laura A.
dc.contributor.authorGumusay, Ozge
dc.contributor.authorIdossa, Dame
dc.contributor.authorRugo, Hope S.
dc.date.accessioned2025-10-16T15:15:45Z
dc.date.issued2023
dc.identifier.doi10.3322/caac.21777
dc.identifier.otherWOS:000953382000001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6527
dc.publisherWILEY
dc.sourceCA-A CANCER JOURNAL FOR CLINICIANS
dc.subjectbreast neoplasms
dc.subjectclinical trials
dc.subjecthormone receptor\\-positive
dc.subjecthormone therapy
dc.subjecthuman epidermal growth factor receptor 2 \\(HER2\\)\\-negative breast cancer
dc.titleSystemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer
dc.typeReview

Dosyalar

Koleksiyonlar

WOS